首页|期刊导航|中华医学杂志(英文版)|Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients:The younger,the better
Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients:The younger,the better
Lan Zhu Yonghua Feng Wenyu Zhao Wenqi Cong Jianyong Wu Changxi Wang Gang Chen Lei Zhang Wenjun Shang Wenhua Liu Rula Sa Zhiliang Guo Longshan Liu Jinghong Tan Hengxi Zhang
中华医学杂志(英文版)2025,Vol.138Issue(2):225-227,3.
中华医学杂志(英文版)2025,Vol.138Issue(2):225-227,3.DOI:10.1097/CM9.0000000000003357
Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients:The younger,the better
Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients:The younger,the better
摘要
引用本文复制引用
Lan Zhu,Yonghua Feng,Wenyu Zhao,Wenqi Cong,Jianyong Wu,Changxi Wang,Gang Chen,Lei Zhang,Wenjun Shang,Wenhua Liu,Rula Sa,Zhiliang Guo,Longshan Liu,Jinghong Tan,Hengxi Zhang..Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients:The younger,the better[J].中华医学杂志(英文版),2025,138(2):225-227,3.基金项目
The study was supported by the Clinical Research Flag-ship Project of Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology(No.2019CR108). (No.2019CR108)